Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Bought by DORCHESTER WEALTH MANAGEMENT Co

DORCHESTER WEALTH MANAGEMENT Co raised its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,670 shares of the pharmacy operator’s stock after purchasing an additional 1,800 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Walgreens Boots Alliance were worth $1,254,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Nuveen Asset Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 216.5% in the second quarter. Nuveen Asset Management LLC now owns 2,281,316 shares of the pharmacy operator’s stock valued at $124,720,000 after acquiring an additional 1,560,622 shares in the last quarter. Morgan Stanley boosted its holdings in shares of Walgreens Boots Alliance by 36.2% in the second quarter. Morgan Stanley now owns 4,913,030 shares of the pharmacy operator’s stock valued at $268,595,000 after acquiring an additional 1,304,949 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.0% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after acquiring an additional 1,169,600 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Walgreens Boots Alliance by 1,518.3% in the third quarter. Assenagon Asset Management S.A. now owns 611,724 shares of the pharmacy operator’s stock valued at $33,834,000 after acquiring an additional 573,924 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its holdings in shares of Walgreens Boots Alliance by 23.4% in the second quarter. Parametric Portfolio Associates LLC now owns 2,893,195 shares of the pharmacy operator’s stock valued at $158,171,000 after acquiring an additional 549,575 shares in the last quarter. Institutional investors own 59.76% of the company’s stock.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.73% of the stock is owned by corporate insiders.

Several analysts have recently weighed in on WBA shares. JPMorgan Chase & Co. lowered their target price on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a report on Friday, June 28th. Royal Bank of Canada downgraded shares of Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price on the stock. in a report on Friday, September 27th. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a report on Thursday, October 3rd. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Wednesday, September 11th. Finally, Deutsche Bank started coverage on shares of Walgreens Boots Alliance in a report on Thursday, September 12th. They issued a “sell” rating on the stock. Seven equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $62.24.

Shares of NASDAQ WBA opened at $55.30 on Friday. Walgreens Boots Alliance Inc has a 12-month low of $49.03 and a 12-month high of $86.31. The company has a market capitalization of $50.52 billion, a PE ratio of 9.19, a price-to-earnings-growth ratio of 1.43 and a beta of 0.89. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The firm’s 50-day moving average is $53.76 and its two-hundred day moving average is $53.39.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What are popular range trading strategies?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.